col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: European Journal Of Haematology
  original article Date Title Authors   All Authors
1 [GO] 2021―May―14 COVID-19 Vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome Massimo Franchini, Giancarlo Maria Liumbruno, Mario Pezzo
2 [GO] 2021―Apr―29 White Blood Count, D-dimers and Ferritin levels as Predictive Factors of Pulmonary Embolism suspected upon admission in noncritically ill COVID-19 patients: the French multicenter CLOTVID retrospective study J Galland, B Thoreau, M Delrue, M Neuwirth, A Stepanian, A Chauvin, et al. (+110)
3 [GO] 2021―Mar―29 Clinical Predictors Of SARS-CoV-2 Neutralizing Antibody Titers In COVID-19 Convalescents: Implications For Convalescent Plasma Donor Recruitment Daniele Focosi, Massimo Franchini
4 [GO] 2021―Feb―20 Long-term follow up of patients with venous thromboembolism and COVID-19: analysis of risk factors for death and major bleeding Pablo Demelo-Rodríguez, Lucía Ordieres-Ortega, Zichen Ji, Jorge del Toro-Cervera, Javier de Miguel-Díez, Luis Antonio Álvarez-Sala-Walther, Francisco Galeano-Valle
5 [GO] 2021―Jan―27 Internet based patient survey on the consequences of COVID-19 lockdown on treatment and medical follow-up of patients with aplastic anemia or paroxysmal nocturnal hemoglobinuria in Germany Fabian Beier, Kim Kricheldorf, Pascale Burmester, Ulrike Göbel, Susanne Isfort, Jens Panse, Tim H Brümmendorf
6 [GO] 2020―Nov―16 The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single center experience Holly Lee, Jason Tay, Peter Duggan, Sylvia McCulloch, Paola Neri, Nizar J Bahlis, Victor H Jimenez-Zepeda
7 [GO] 2020―Oct―12 Association of Anticoagulation Dose and Survival in Hospitalized COVID-19 Patients: A Retrospective Propensity Score Weighted Analysis Filip Ionescu, Ishmael Jaiyesimi, Ioana Petrescu, Patrick R Lawler, Edward Castillo, Yolanda Munoz-Maldonado, et al. (+5)
8 [GO] 2020―Sep―26 Transfusion requirements in patients with COVID-19 A.P. Worrall, C. Kelly, A. O’Neill, N Reidy, M. O’Doherty, L Griffin, et al. (+11)
9 [GO] 2020―Sep―17 SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study Andreas Glenthøj, Lasse H Jakobsen, Henrik Sengeløv, Syed A Ahmad, Kristian Qvist, Annika Rewes, et al. (+18)
10 [GO] 2020―Aug―14 Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19 Irene Pakos, Kevin Bryan Lo, Grace Salacup, Jerald Pelayo, Ruchika Bhargav, Eric Peterson, et al. (+6)
11 [GO] 2020―Aug―04 COVID-19 coagulopathy: an in-depth analysis of the coagulation system Reyes María Martín-Rojas, Gloria Pérez-Rus, Valeria Estefania Delgado-Pinos, Amalia Domingo-González, Isabel Regalado-Artamendi, Natalia Alba-Urdiales, et al. (+7)
12 [GO] 2020―Aug―03 Outcome of COVID-19 in multiple myeloma patients in relation to treatment Katharina Helene Susek, Charlotte Gran, Hans-Gustaf Ljunggren, Evren Alici, Hareth Nahi
13 [GO] 2020―Jul―25 Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies José María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, Rodrigo Gil Manso, Rafael Colmenares, Daniel Gil Alos, et al. (+20)
14 [GO] 2020―Jul―14 Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy Charles Agbuduwe, Supratik Basu
15 [GO] 2020―Jun―27 Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis Steffen Koschmieder, Edgar Jost, Christian Cornelissen, Tobias Müller, Maximilian Schulze-Hagen, Johannes Bickenbach, et al. (+5)
16 [GO] 2020―Jun―27 Sickle Cell Trait and The Potential Risk of Severe Coronavirus Disease 2019- A Mini-Review Tawakalitu Abosede Kehinde, Mayowa Azeez Osundiji
17 [GO] 2020―Jun―27 Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: challenges and measurable outcomes Faouzi Djebbari, Fotios Panitsas, Faye A. Sharpley, Alexandros Rampotas, Jemma Larham, Sally Moore, et al. (+3)
18 [GO] 2020―Jun―23 COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation Dimitrios Farmakis, Anastasios Giakoumis, Lily Cannon, Michael Angastiniotis, Androulla Eleftheriou
19 [GO] 2020―Jun―23 COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia Petra Langerbeins, Moritz Fürstenau, Henning Gruell, Florian Klein, Thorsten Persigehl, Jan Rybniker, et al. (+6)
20 [GO] 2020―Jun―17 Janus faced course of COVID-19 infection in patients with hematological malignancies Rosa Bellmann-Weiler, Francesco Burkert, Theresa Schwaiger, Stephan Schmidt, Christof Ludescher, Horst Oexle, et al. (+2)
21 [GO] 2020―Jun―16 Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy Stephen Booth, John Willan, Henna Wong, Dalia Khan, Rachel Farnell, Alicia Hunter, et al. (+14)
22 [GO] 2020―Jun―05 Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection T.P Afra, Ram Vasudevan Nampoothiri, Muhammed Razmi T
23 [GO] 2020―Apr―23 COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency Yan Beauverd, Yannick Adam, Benjamin Assouline, Kaveh Samii


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.009 sec